Shahyar Gharacholou, MD
Cardiovascular Disease · Jacksonville, FLNPI 1477752715
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $884 of the $1,191 with a category attached, or 74.2%. Abbott accounts for 93.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for cardiovascular disease clinicians in FL, where the typical reported total is $2,774.
Across 10 payments — averaging $119.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Medtronic$72
Across 20 payments — averaging $5654.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- American Regent$113K
What the payments were for
- Travel & lodging$88474%
- Food & beverage$30726%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,191 in reported general payments places this provider in the 30th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $33,211 |
| XareltoRivaroxaban | 11 | $13,519 |
| Repatha SyringeEvolocumab | 11 | $6,204 |
| Metoprolol Succinate | 59 | $1,044 |
| Ranolazine ErRanolazine | 11 | $1,021 |
| Atorvastatin Calcium | 76 | $887 |
| Losartan Potassium | 51 | $752 |
| Rosuvastatin Calcium | 35 | $605 |
| Amlodipine Besylate | 41 | $579 |
| Carvedilol | 13 | $249 |
| Ezetimibe | 11 | $247 |
| ClopidogrelClopidogrel Bisulfate | 22 | $233 |
| Nitroglycerin | 14 | $195 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $59 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Jacksonville
- Alan MillerJacksonville$547K
- Samer GarasJacksonville$258K
- Jose Nativi-NicolauJacksonville$125K
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Seth BaumBoca Raton$517K
- Elliott EliasMiami$497K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.